Online Inquiry

2'-F Modification Service of siRNA

At Protheragen BioNucleics, we understand the critical role of siRNA modifications in advancing oligonucleotide therapeutics. Our comprehensive Oligonucleotide Drugs CRO services are designed to meet the evolving needs of the pharmaceutical industry. Specializing in Oligonucleotide Modification Service and siRNA Modification Service, we offer cutting-edge solutions to enhance the stability and efficacy of siRNA molecules.

Overview of siRNA 2'-F Modification Service

The 2'-fluoro (2'-F) modification of siRNA is a pivotal technique to improve the pharmacokinetic properties of siRNA therapeutics. By substituting the hydroxyl group at the 2' position of the ribose sugar with a fluorine atom, we significantly enhance the nuclease resistance and thermal stability of siRNA molecules without compromising their silencing efficiency. At Protheragen BioNucleics, we have developed an advanced 2'-F modification service that enables the design and synthesis of highly stable and effective siRNA candidates for research applications.

Our 2'-F Modification Services

At Protheragen BioNucleics, we are dedicated to providing comprehensive 2'-F modification services for siRNA molecules. Our expertise in nucleic acid chemistry and state-of-the-art facilities enable us to deliver high-quality modified siRNAs that meet the stringent requirements of pharmaceutical research and development.

Custom Synthesis of 2'-F Modified siRNA

 We offer custom synthesis of siRNA duplexes incorporating 2'-F modifications at specific positions. Our chemists meticulously design and synthesize siRNA sequences with selective 2'-F substitutions to enhance nuclease resistance and binding affinity. The strategic placement of 2'-F modifications can be tailored to optimize the balance between stability and target gene silencing efficacy.

Advanced Phosphoramidite Chemistry

Utilizing advanced phosphoramidite chemistry, we synthesize 2'-F nucleoside analogs with high purity and efficiency. Our proprietary synthesis protocols ensure that the modified nucleotides are incorporated seamlessly into the siRNA backbone, maintaining the structural integrity and biological function of the molecule.

Optimization of siRNA Stability and Activity

Through our rigorous analytical and optimization processes, we evaluate the thermal stability, nuclease resistance, and gene silencing activity of 2'-F modified siRNAs. We employ techniques such as UV melting analysis, nuclease degradation assays, and cell-based gene knockdown studies to assess and enhance the performance of the modified siRNAs.

Comprehensive Analytical Characterization

Quality control is paramount in our services. We provide comprehensive analytical characterization of the modified siRNAs, including mass spectrometry, HPLC purification profiles, and electrophoresis analysis. This ensures that the final products meet the highest standards of purity and functionality required for therapeutic applications.

Scale-Up Production and GMP Manufacturing

For clients progressing towards preclinical development, we offer scale-up production and GMP manufacturing of 2'-F modified siRNAs. Our facilities are equipped to produce large quantities of siRNA with consistent quality, adhering to regulatory guidelines for pharmaceutical manufacturing.

Consultation and Technical Support

Our team of experts provides consultation services to assist clients in designing optimal siRNA sequences with 2'-F modifications. We offer technical support throughout the project, from initial design to final delivery, ensuring that our clients achieve their research objectives efficiently.

Frequently Asked Questions

Q1: What advantages does 2'-F modification provide for siRNA molecules?

2'-F modification enhances siRNA stability by increasing resistance to nuclease degradation. It also improves thermal stability without affecting the RNA interference activity, leading to more effective and durable gene silencing.

Q2: Can 2'-F modifications affect the specificity of siRNA targeting?

When properly designed, 2'-F modifications do not adversely affect the specificity of siRNA targeting. Our experts ensure that the modifications are strategically placed to maintain high specificity and efficacy in gene silencing.

Q3: Do you offer assistance in designing siRNA sequences with 2'-F modifications?

Yes, we provide consultation services to help design optimal siRNA sequences with 2'-F modifications. Our team can assist in selecting modification sites to achieve the desired balance between stability and activity.

Our services and products are exclusively for authorized organizations in research, development, or manufacturing and are not intended for direct use by individuals or patients or as medical advice, diagnosis, or treatment.

Online Inquiry